Related Experiment Video
Updated: Mar 15, 2026
10:57
Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
Published on: July 13, 2015
13.2K
Summary
The Formulary Monograph Service provides monthly drug monographs for Pharmacy & Therapeutics Committees, including comprehensive drug utilization evaluations (DUE/MUE). Subscribers gain online access to customized monographs on new and emerging pharmaceutical agents.
Area of Science:
- Pharmaceutical Science
- Clinical Pharmacy
- Drug Information
Background:
- Pharmacy & Therapeutics (P&T) Committees require timely, evidence-based drug information.
- New drug approvals and late-stage trials necessitate thorough evaluation for formulary inclusion.
- Drug utilization evaluation (DUE) and medication use evaluation (MUE) are critical for optimizing therapeutic outcomes and managing costs.
Purpose of the Study:
- To provide P&T Committees with detailed monographs on newly released or late-phase drugs.
- To offer concise summary monographs for pharmacy and nursing in-service education.
- To deliver comprehensive DUE/MUE for selected agents.
Main Methods:
- Publication of 5-6 detailed monographs per month covering new and investigational drugs.
- Inclusion of 1-page summary monographs for broader educational use.
- Provision of a comprehensive DUE/MUE with each monthly subscription.
Main Results:
- Subscribers receive monthly updates on drugs such as pimavanserin, venetoclax, defibrotide, lifitegrast, and atezolizumab.
- Online access to monographs is available for subscribers.
- Monographs can be customized to facility-specific needs.
Conclusions:
- The Formulary Monograph Service supports informed drug decision-making for P&T Committees.
- The service facilitates efficient drug evaluation and educational initiatives within healthcare facilities.
- Access to customized, evidence-based drug information enhances medication safety and efficacy.
Related Concept Videos
01:19Depolarizing Blockers: Pharmocokinetics
695
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
695
01:28Depolarizing Blockers: Mechanism of Action
3.3K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
3.3K
01:24Parenteral Anesthetics: Overview
870
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
870
01:21Skeletal Muscle Relaxants: Adverse Effects
1.0K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
1.0K
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
1.1K
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
1.1K
01:26EDTA: Auxiliary Complexing Reagents
1.5K
EDTA titrations are usually carried out in highly basic conditions, where the fully deprotonated form of EDTA, Y4−, actively complexes with the free metal ions in the solution. Several metal ions precipitate as hydrous oxide (hydroxides, oxides, or oxyhydroxides) under these conditions, lowering the concentration of free metal ions in the solution. For this reason, auxiliary complexing agents or ligands such as ammonia, tartrate, citrate, or triethanolamine are used in EDTA titrations to...
1.5K